Overall, all of the alterations identified using standard techniques were confirmed via OGM, but additional rearrangements generating fusion genes were revealed, allowing for the reclassification of 3 patients as B-ALL with TCF3::PBX1 and BCR::ABL1-like B-ALL. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.